رجوع
نطاق اليوم
KWD 87.99
KWD 90.94
نطاق 52 أسبوعًا
KWD 79.52
KWD 124.00
حجم التداول
1,191,903
متوسط 50 يوم / 200 يوم
KWD 105.31
/
KWD 104.33
الإغلاق السابق
KWD 89.27
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -20.4 | 0.4 |
| P/B | 1.2 | 2.9 |
| ROE % | -5.7 | 3.8 |
| Net Margin % | -39.6 | 3.9 |
| Rev Growth 5Y % | -38.3 | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 137.380
+55.4%
Low: KWD 113.000
High: KWD 155.000
ربحية السهم المستقبلية
-KWD 4.336
الإيرادات المقدّرة
2.3 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
-KWD 0.065
-KWD 0.085 – -KWD 0.050
|
3.7 B | 3 |
| FY2029 |
-KWD 2.476
-KWD 3.237 – -KWD 1.903
|
2.9 B | 3 |
| FY2028 |
-KWD 3.237
-KWD 9.145 – -KWD 0.731
|
2.8 B | 9 |
النقاط الرئيسية
Revenue declined -38.26% annually over 5 years
Debt/Equity of 0.01 — conservative balance sheet
Generating 269.81M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 38.46%
Capital efficient — spends only 6.10% of revenue on capex
النمو
Revenue Growth (5Y)
-38.26%
Revenue (1Y)0.20%
Earnings (1Y)N/A
FCF Growth (3Y)-75.95%
الجودة
Return on Equity
-5.65%
ROIC-2.40%
Net Margin-39.59%
Op. Margin-22.63%
الأمان
Debt / Equity
0.01
Current Ratio7.54
Interest Coverage-45.74
التقييم
P/E Ratio
-20.36
P/B Ratio1.16
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.20% | Revenue Growth (3Y) | -15.04% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -38.26% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2.76B | Net Income (TTM) | -1.09B |
| ROE | -5.65% | ROA | -4.96% |
| Gross Margin | 77.64% | Operating Margin | -22.63% |
| Net Margin | -39.59% | Free Cash Flow (TTM) | 269.81M |
| ROIC | -2.40% | FCF Growth (3Y) | -75.95% |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 7.54 |
| Interest Coverage | -45.74 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -20.36 | P/B Ratio | 1.16 |
| P/S Ratio | 8.06 | PEG Ratio | -0.29 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 22.22B | Enterprise Value | 14.81B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.76B | 2.75B | 3.82B | 17.31B | 18.98B |
| Net Income | -1.09B | -665.30M | 930.30M | 9.43B | 10.29B |
| EPS (Diluted) | -4.51 | -2.77 | 3.83 | 37.09 | 41.21 |
| Gross Profit | 2.14B | 2.21B | 3.22B | 14.32B | 16.07B |
| Operating Income | -623.87M | -1.31B | 690.40M | 12.64B | 15.28B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 21.98B | 22.53B | 23.01B | 23.28B | 15.83B |
| Total Liabilities | 2.76B | 3.12B | 2.76B | 3.22B | 3.94B |
| Shareholders' Equity | 19.22B | 19.41B | 20.25B | 20.06B | 11.89B |
| Total Debt | 267.29M | 254.20M | 219.10M | 212.20M | 301.50M |
| Cash & Equivalents | 7.67B | 9.76B | 11.66B | 13.88B | 1.69B |
| Current Assets | 16.14B | 18.80B | 19.53B | 21.92B | 15.07B |
| Current Liabilities | 2.14B | 2.52B | 2.07B | 2.95B | 3.48B |